Conflicting rulings set up an extraordinary legal clash and could reshape abortion access in a nation where reproductive rights remain a polarizing issue.
‘This opens the door to the courts’ second-guessing any FDA approval — especially for drugs for controversial areas like gender-affirming care,’ expert says.
The report highlighted the prevalence of infertility across regions and economic levels — and a need for more research and better access to reproductive care.
The report highlighted the prevalence of infertility across regions and economic levels — and a need for more research and better access to reproductive care.